10.25
Electrocore Inc stock is traded at $10.25, with a volume of 153.52K.
It is up +0.69% in the last 24 hours and up +53.10% over the past month.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
See More
Previous Close:
$10.18
Open:
$10.17
24h Volume:
153.52K
Relative Volume:
1.53
Market Cap:
$85.03M
Revenue:
$34.90M
Net Income/Loss:
$-15.38M
P/E Ratio:
-5.6552
EPS:
-1.8125
Net Cash Flow:
$-6.87M
1W Performance:
+17.55%
1M Performance:
+53.10%
6M Performance:
+115.79%
1Y Performance:
+90.88%
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ECOR
Electrocore Inc
|
10.25 | 85.03M | 34.90M | -15.38M | -6.87M | -1.8125 |
|
ABT
Abbott Laboratories
|
88.18 | 153.59B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
312.20 | 119.69B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
80.20 | 102.97B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
46.91 | 69.72B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
85.11 | 49.01B | 6.30B | 1.07B | 1.09B | 1.8406 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
Former electrocore officer Daniel S. Goldberger sold $544,000 in shares - Investing.com
ECOR | electroCore, Inc. Common Stock Insider Trading - Quiver Quantitative
ElectroCore Insider Sold Shares Worth Over $544K - TradingView
electroCore (ECOR) ex-officer sells 80,000 shares, keeps 211,471 - Stock Titan
New review says vagus nerve can be stimulated without surgery - Stock Titan
electroCore (ECOR) Sinks Over 12% – Key Support Level Under ThreatWyckoff Accumulation - newsline.com
ECOR Q1 2026 Earnings: EPS Beats Estimates by 40.76%, Stock Declines 12.27%Return On Capital - newsline.com
electroCore, Inc. Hits New 52-Week High of $10.27, Reflecting Strong Growth - MarketsMojo
electroCore, Inc. Hits New 52-Week High of $10.35, Reflecting Strong Growth - MarketsMojo
electroCore, Inc. Hits New 52-Week High of $9.18, Surpassing Previous Milestones - Markets Mojo
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub - Yahoo Finance
electroCore Inc. (ECOR) Q1 2026 Earnings: EPS Surges Past Estimates by 40.76%Long-Term Guidance - The Legal Advocate
electroCore Inc. (ECOR) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Investor Sentiment - The Legal Advocate
Electrocore CFO and interim president Lev sells $60,003 of company stock By Investing.com - Investing.com South Africa
electroCore Inc. (ECOR) Gains Ground: Bullish Move Toward ResistancePSAR Stop - The Legal Advocate
Electrocore CFO and interim president Lev sells $60,003 of company stock - Investing.com Nigeria
electroCore (ECOR) CFO sells 6,667 shares in open-market trade - Stock Titan
ElectroCore Inc. (ECOR) Surges 3.9% as Stock Approaches Key Resistance LevelOBV Breakout - The Legal Advocate
electroCore, Inc. Hits New 52-Week High of $9.64, Reflecting Strong Growth - MarketsMojo
electroCore (ECOR) insider sale: 3,000 shares for $19,500 reported - Stock Titan
ECOR (NASDAQ: ECOR) files Form 144 notice reporting proposed insider sales - Stock Titan
ECOR Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Shares HigherEBITDA Analysis - The Legal Advocate
Electrocore director Thomas J. Errico buys $59,852 in stock By Investing.com - Investing.com Nigeria
electroCore Stock (ECOR) Opinions on Recent Surge and Clinical Validation - Quiver Quantitative
ElectroCore (ECOR) Surges 33% as Trading Volume Spikes – Key Levels in FocusDescending Triangle - The Legal Advocate
Electrocore director Thomas J. Errico buys $59,852 in stock - Investing.com
electroCore (ECOR) director boosts stake with 9,992-share open-market buy - Stock Titan
electroCore Inc. (ECOR) Q1 2026 Earnings: EPS Surprise Drives Stock RallyDividend Growth Analysis - The Legal Advocate
ElectroCore touts 30% growth outlook, VA opportunity at LD Micro Conference - MSN
ElectroCore CFO sells $19,500 in shares - Investing.com India
ElectroCore CFO sells $19,500 in shares By Investing.com - Investing.com India
electroCore (ECOR) CFO sells 3,000 shares to cover RSU taxes - Stock Titan
electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference - Yahoo Finance
Relay Therapeutics (RLAY) surges 16.4%: Is this an indication of further gains? - MSN
ECOR: Rapid growth, unique vagus nerve tech, and new partnerships drive future expansion - TradingView
electroCore (ECOR) Stock: Down -2.49%, Support Test at $5.96 2026-05-17Dealer Delta - Newser
ElectroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026 - marketscreener.com
electroCore (ECOR) Drops -5.29% — Key Support at $5.79 2026-05-15Imbalance Zone - Newser
electroCore (ECOR) Q1 2026 Earnings Transcript - AOL.com
Vagus Nerve Stimulators Market to Reach USD 1.86 Billion by 2033 - openPR.com
ECOR (NASDAQ) brokered sale notice: 45,000 shares valued $291,600 - Stock Titan
Quell device shows pain reduction in fibromyalgia study By Investing.com - Investing.com India
electroCore (ECOR) Reports Positive Fibromyalgia Trial Results - GuruFocus
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):